Vera Therapeutics, Inc.

VERA

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001831828

SEC filings (opens in a new tab)

In the last 90 days, Vera Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 219 institutions reported holding it in 13F filings for Q2 2026, worth $3.34B in total; no superinvestor holds it.

Q3 2024 vs. Q2 2024

How the institutions holding Vera Therapeutics, Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024 All holders in Q2 2024

13F holders of VERA: Q2 2024 compared with Q3 2024
Measure	Q2 2024	Of which not filed for Q3 2024	Q3 2024	Change
Holders	171	1	173	+3
Shares	53.0M	3.34M	53.5M	+3.87M (+7.8%)
Value	$1.92B	$120.8M	$2.37B	+$568.7M (+31.7%)

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (27)

Institutions that held Vera Therapeutics, Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to VERA in Q3 2024
Institution	Shares	Value	% of portfolio
BlackRock, Inc.	3,452,202	$152.6M	0.00%
Paradigm Biocapital Advisors LP	1,096,851	$48.5M	1.70%
T. Rowe Price Investment Management, Inc.	984,001	$43.5M	0.03%
Siren, L.L.C.	837,928	$37.0M	1.85%
Pier Capital, LLC	103,463	$4.57M	0.64%
Eastern Bank	56,050	$2.48M	0.04%
Trexquant Investment LP	51,839	$2.29M	0.03%
Verition Fund Management LLC	43,210	$1.91M	0.01%
Thornburg Investment Management Inc	30,880	$1.36M	0.02%
Tudor Investment Corp Et Al	24,478	$1.08M	0.01%
Skandinaviska Enskilda Banken AB (publ)	17,101	$755.9K	0.00%
Harvest Investment Services, LLC	16,313	$721.0K	0.23%
Qube Research & Technologies Ltd	13,376	$591.2K	0.00%
Bayesian Capital Management, LP	11,722	$518.1K	0.06%
Intech Investment Management LLC	10,737	$474.6K	0.01%
Brevan Howard Capital Management LP	7,614	$336.5K	0.02%
AlphaCentric Advisors LLC	7,500	$331.5K	0.25%
Westover Capital Advisors, LLC	6,224	$275.1K	0.05%
Acadian Asset Management LLC	2,185	$96.0K	0.00%
Catalyst Funds Management Pty Ltd	1,200	$53.0K	0.01%
Bessemer Group Inc	35	$2.00K	0.00%
Aster Capital Management (DIFC) Ltd	44	$1.95K	0.00%
Sterling Capital Management LLC	40	$1.77K	0.00%
Federation des caisses Desjardins du Quebec	20	$884	0.00%
Parallel Advisors, LLC	15	$663	0.00%
Fortitude Family Office, LLC	14	$619	0.00%
Capital Performance Advisors LLP	11	$486	0.00%

Sold out (24)

Institutions that held Vera Therapeutics, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of VERA in Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
Artal Group S.A.	915,974	$33.1M
Polar Capital Holdings Plc	675,000	$24.4M
Renaissance Technologies LLC	147,800	$5.35M
Twinbeech Capital LP	93,176	$3.37M
EAM Investors, LLC	62,355	$2.26M
Healthcare of Ontario Pension Plan Trust Fund	37,400	$1.35M
Captrust Financial Advisors	31,186	$1.13M
Engineers Gate Manager LP	19,524	$706.4K
Magnetar Financial LLC	18,021	$652.0K
William Marsh Rice University	16,397	$593.2K
Adams Street Partners LLC	13,114	$474.5K
Fox Run Management, L.L.C.	12,198	$441.3K
Group One Trading, L.P.	12,058	$436.3K
SEI Investments Co	10,824	$391.6K
Seven Eight Capital, LP	9,243	$334.4K
Principal Financial Group Inc	7,230	$261.6K
J. Goldman & Co LP	6,800	$246.0K
Deerfield Management Company, L.P. (Series C)	6,191	$224.0K
Belvedere Trading LLC	5,279	$191.0K
Aquatic Capital Management LLC	3,100	$112.2K
ADAR1 Capital Management, LLC	1,079	$39.0K
Pacer Advisors, Inc.	693	$25.1K
Quest Partners LLC	125	$4.52K
Innealta Capital, LLC	42	$1.52K

Not filed for Q3 2024 yet (1)

Institutions that held Vera Therapeutics, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding VERA in Q2 2024 that haven't filed for Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
BlackRock Inc.	3,337,672	$120.8M